Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults

Journal of Alzheimer's Disease

Volumn 43, Issue 2, 2015, Pages 677-686

  Hollands, Simone ^a   Lim, Yen Ying ^b,c   Buckley, Rachel ^b   Pietrzak, Robert H ^d   Snyder, Peter J ^c   Ames, David ^b,e   Ellis, Kathryn A ^b   Harrington, Karra ^b   Lautenschlager, Nicola ^b,f   Martins, Ralph N ^g   Masters, Colin L ^b   Villemagne, Victor L ^b,h   Rowe, Christopher C ^b,h   Maruff, Paul ^b,i  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c BROWN UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL AGEING RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g EDITH COWAN UNIVERSITY   (Australia)

^h AUSTIN HEALTH   (Australia)

ⁱ Scientific Division   (Australia)

Author keywords

Amyloid; cognitive; depression; subjective memory impairment

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B; APOLIPOPROTEIN E4;

ADULT; AGED; ANXIETY; ARTICLE; COGNITION; COGNITIVE DEFECT; COGSTATE BRIEF BATTERY; DEPRESSION; FEMALE; HUMAN; INFORMANT QUESTIONNAIRE ON COGNITIVE DECLINE IN THE ELDERLY; MAJOR CLINICAL STUDY; MALE; MEMORY COMPLAINT QUESTIONNAIRE; MEMORY DISORDER; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPSYCHOLOGICAL TEST; WORKING MEMORY; ANALYSIS OF VARIANCE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; GENETICS; MEMORY DISORDERS; METABOLISM; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; QUESTIONNAIRE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; APOLIPOPROTEIN E4; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; QUESTIONNAIRES;

EID: 84911871391     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140678     Document Type: Article

References (39)

1. Peterson R (2004) Mild cognitive impairment as a diagnosticentity. J Intern Med 256, 183-194.
2. Weaver Cargin J, Collie A, Masters C, Maruff P (2008) Thenature of cognitive complaints in healthy older adults with andwithout objective memory decline. J Clin Exp Neuropsychol30, 1-13.
3. Deloitte Access Economics (2011) Dementia across Australia:2011-2050. http://www. fightdementia. org. au/common/files/NAT/20111014 Nat Access DemAcrossAust. pdf
4. Jessen F, Wolfsgrubera S, Wiesec B, Bickeld H, MD oschd E, Kaduszkiewicze H, Pentzekf M, Riedel-Hellerg SG, Luckg T, Fuchsf A, Weyererh S, Werleh J, van den Busschee H, Scherere M, Maiera W, Wagnera M (2014) AD dementiarisk in late MC I, in early MC I, and in subjective memoryimpairment. Alzheimers Dement 10, 76-83.
5. Caselli RJ, Chen K, Locke DE C, Lee W, Roontiva A, Bandy D, Fleisher AS, Reiman EM (2014) Subjective cognitive decline:Self and informant comparisons. Alzheimers Dement 10, 93-98.
6. Steffens DC, Potter GG (2008) Geriatric depression and cognitiveimpairment. Psychol Med 38, 163-175.
7. Pijnenburg YA, Gillissen F, Jonker C, Scheltens P (2004) Initialcomplaints in frontotemporal lobar degeneration. DementGeriatr Cogn Disord 17, 302-306.
8. Balash Y, Mordechovich M, Shabtai H, Giladi N, Gurevich T, Korczyn AD (2012) Subjective memory complaints in elders:Depression, anxiety, or cognitive decline Acta Neurol Scand127, 344-350.
9. Bartley M, Bokde AL, Ewers M, Faluyi YO, Tobin WO, Snow A, Connolly J, Delaney C, Coughlan T, Collins DR, Hampel H, O'Neill D (2012) Subjective memory complaintsin community dwelling healthy older people: The influenceof brain and psychopathology. Int J Geriatr Psychiatry 27, 836-843.
10. Jorm AF, Butterworth P, Anstey KJ, Christensen H, Easteal S, Maller J, Mather A, Turakulov RI, Wen W, Sachdev P (2004) Memory complaints in a community sampleaged 60-64 years: Associations with cognitive functioning, psychiatric symptoms, medical conditions, APOE genotype, hippocampus and amygdala volumes, and white-matterhyperintensities. Psychol Med 34, 1495-1506.
11. Minett TS C, Da Silva RV, Ortiz KZ, Bertolucci PHF (2008) Subjective memory complaints in an elderly sample: A crosssectionalstudy. Int J Geriatr Psychiatry 23, 49-54.
12. Antonell A, Fortea J, Rami L, Bosch B, Balasa M, Sánchez-Valle R, Iranzo A, Molinuevo JL, Lladó A (2011) Differentprofiles of Alzheimer's disease cerebrospinal fluid biomarkersin controls and subjects with subjective memory complaints. J Neural Transm 118, 259-262.
13. Grambaite R, Hessen E, Auning E, Aarsland D, Selnes P, Fladby T (2013) Correlates of subjective and mild cognitiveimpairment: Depressive symptoms and CSF biomarkers. Dement Geriatr Cogn Disord Extra 3, 291-300.
14. Buckley R, Saling MM, Ames D, Rowe CC, Lautenschlager NT, Macaulay SL, Martins RN, Masters CL, O'Meara T, Savage G, Szoeke C, Villemagne VL, A, EK (2013) Factorsaffecting subjective memory complaints in the AIBL agingstudy: Biomarkers, memory, affect, and age. Int Psychogeriatr25, 1307-1315.
15. Amariglio RE, Becker JA, Carmasin J, Wadsworth LP, Lorius N, Sullivan C, Maye JE, Gidicsin C, Pepin LC, Sperling RA, Johnson KA, Rentz DM (2012) Subjective cognitivecomplaints and amyloid burden in cognitively normal olderindividuals. Neuropsychologia 50, 2880-2886.
16. Rodda J, Okello A, Edison P, Dannhauser T, Brooks DJ, Walker Z (2010) 11C-PIB PET in subjective cognitive impairment. Eur Psychiatry 25, 123-125.
17. Pike KE, Ellis KA, Villemagne VL, Good N, Chételat G, Ames D, Szoeke C, Laws SM, Verdile G, Martins RN, Masters CL, Rowe CC (2011) Cognition and beta-amyloid inpreclinical Alzheimer's disease: Data from the AIBL study. Neuropsychologia 49, 2384-2390.
18. Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust WJ (2012) Subjective cognition and amyloid deposition imaging:APittsburgh Compound Bpositron emission tomographystudy in normal elderly individuals. Arch Neurol 69, 223-229.
19. van Harten AC, Smits LL, Teunissen CE, Visser PJ, Koene T, Blankenstein MA, Scheltens P, van der Flier WM (2013) Preclinical AD predicts decline in memory and executivefunctions in subjective complaints. Neurology 81, 1409-1416.
20. Johnson S, Christian B, Okonkwo O, Oh J, Harding S, Xu G, Hillmer A, Wooten D, Murali D, Barnhart T, Hall L, Racine A, Klunk W, Mathis C, Bendlin B, Gallagher C, Carlsson C, Rowley H, Hermann B, Dowling N, Asthana S, Sager M (2014) Amyloid burden and neural function in people at riskfor Alzheimer's Disease. Neurobiol Aging 35, 576-584.
21. Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, Rowe CC (2010) Relationship betweenatrophy and-amyloid deposition in Alzheimer disease. Ann Neurol 67, 317-324.
22. Mielke MM, Wiste HJ, Weigand SD, Knopman DS, Lowe VJ, Roberts RO, Geda YE, Swenson-Dravis D, Boeve BF, Senjem ML, Vemuri P, Peterson RC, Jack CR (2012) Indicators ofamyloid burden in a population-based study of cognitivelynormal elderly. Neurology 79, 1570-1577.
23. Hohman T, Beason-Held L, Lamar M, Resnick S (2011) Subjective cognitive complaints and longitudinal changes inmemory and brain function. Neuropsychology 25, 125-130.
24. Resnick SM, Sojkova J, Zhou Y, An Y, Ye W, Holt DP, Dannals RF, Mathis CA, Klunk WE, Ferrucci L, Kraut MA, WongDF (2010) Longitudinal cognitive decline is associated withfibrillar amyloid-beta measured by[11C]PiB. Neurology 74, 807-815.
25. Lim YY, Ellis KA, Pietrzak RH, Ames D, Darby D, Harrington K, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Villemagne VL, Maruff P (2012) Stronger effect of amyloidload than APOE genotype on cognitive decline in healthyolder adults. Neurology 79, 1645-1652.
26. Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL (2013) Amyloid-deposition, neurodegeneration, and cognitive decline in sporadicAlzheimer's disease: A prospective cohort study. Lancet Neurol12, 357-367.
27. Stomrud E, Hansson O, Zetterberg H, Blennow K, Minthon L, Londos E (2010) Correlation of longitudinal cerebrospinalfluid biomarkers with cognitive decline in healthy older adults. Arch Neurol 67, 217-223.
28. Abdulrab K, Heun R (2008) Subjective memory impairment. Areviewof its definitions indicates the need for a comprehensiveset of standardised and validated criteria. Eur Psychiatry23, 321-330.
29. Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NT, Lenzo N, Martins RN, Maruff P, Masters C, Milner A, Pike K, Rowe C, Savage G, Szoeke C, Taddei K, Villemagne V, Woodward M, Ames D (2009) The AustralianImaging, Biomarkers and Lifestyle (AIBL) study of aging:Methodology and baseline characteristics of 1112 individualsrecruited for a longitudinal study of Alzheimer's disease. IntPsychogeriatr 21, 672-687.
30. Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D, Villemagne VL (2010) Amyloid imaging results from theAustralian Imaging, Biomarkers and Lifestyle (AIBL) studyof aging. Neurobiol Aging 31, 1275-1283.
31. Wechsler D(2001) Wechsler test of adult reading: Examiner'smanual. The Psychological Corporation, San Antonia, TX.
32. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mentalstate examination: A practical method for grading the cognitivestate of patients for the clinician. J Psychiatr Res 12, 189-198.
33. Zigmond AS, Snaith RP (1983) The hospital anxiety anddepression scale. Acta Neurol Scand 67, 361-370.
34. Crook TH, Feher EP, Larrabee GJ (1992) Assessment of memorycomplaint in age-associated memory impairment: TheMAC-Q. Int Psychogeriatr 4, 165-176.
35. Jorm AF (1994) A short form of the informant questionnaireon cognitive decline in the elderly (IQCODE) . Psychol Med24, 145-153.
36. Lim YY, Ellis KA, Harrington K, Ames D, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Darby D, Maruff P (2012) Use of the CogState Brief Battery in the assessmentof Alzheimer's disease related cognitive impairment in theAustralian Imaging, Biomarkers and Lifestyle (AIBL) study. J Clin Exp Neuropsychol 34, 345-358.
37. Maruff P, Lim YY, Darby D, Ellis KA, Pietrzak RH, Snyder PJ, Bush AI, Szoeke C, Schembri A, Ames D, Masters CL (2013) Clinical utility of the cogstate brief battery in identifyingcognitive impairment in mild cognitive impairment and Alzheimer's disease. BMC Pharmacol Toxicol 1, 1-30.
38. Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, Bourgeat P, Ackermann U, Jones G, Szoeke C, Salvado O, Martins R, O'Keefe G, Mathis CA, Klunk WE, Ames D, Masters CL, Rowe CC (2011) Longitudinal assessment ofA-and cognition in aging and Alzheimer disease. Ann Neurol 69, 181-192.
39. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the NationalInstitute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement 7, 280-292.